Project Grant R34CA289918
Award Date
9/18/24
Completion Date
8/31/27
Dollars Obligated
$638K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) to Northwestern University is intended to examine physical activity promotion intervention outcomes, barriers, and facilitators in breast cancer survivors with fatigue. The $130,001 award will fund a study that includes secondary data analyses from a prior mobile health physical activity intervention, as well as a needs assessment to understand multi-level stakeholder perspectives on barriers and...
This federal Project Grant award, in the amount of $594,734, was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) to investigate the effects of a telehealth exercise program for rural cancer survivors experiencing cancer-related fatigue. The primary objectives are to evaluate the efficacy of the "BFITBWell Telehealth Program" for improving cancer-related fatigue in rural breast and prostate cancer survivors, and to examine the...
This Project Grant award of $752,588 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support a 12-week randomized controlled trial to evaluate the effects of time-restricted eating on cancer-related fatigue among survivors of hematological malignancies. The study will assess the impact of a 10-hour daytime feeding window with 14-hour overnight fasting on patient-reported fatigue, circadian rhythms, and glucose metabolism. The University of Maryland, Baltimore...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports a research project at the University of Miami aimed at improving the survival rate of patients with metastatic, endocrine-resistant breast cancer. The $447,340 award, effective March 1, 2025 through February 28, 2030, will fund research to identify epigenetic vulnerabilities and therapeutic targets in breast cancer cells that have developed resistance to endocrine therapy. Specifically,...
This Project Grant award of $621,732 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to evaluate a proactive identification and digital mental health intervention approach to address the unmet psychosocial needs of individuals living with likely incurable cancer. The key products or services to be delivered through this 5-year grant include: 1) Comprehensively assessing the effectiveness of a proactive identification method paired with...
This federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides funding of $1,019,587 to 5 Point App, Inc. to conduct a decentralized clinical trial of the EnergyPoints mobile app. The app is designed to guide cancer survivors in using acupressure self-care techniques to manage fatigue and sleep disturbances, two common and debilitating symptoms experienced by cancer patients. The 2-year project will evaluate...
This Project Grant award of $700,049 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will fund a study on the impact of targeted tyrosine kinase inhibitor (TKI) therapies on cancer-related cognitive impairment (CRCI) among patients with chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). The study, led by the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, will recruit 200 patients about to begin TKI treatment for CML or CLL,...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...
This federal Project Grant award of $1,619,065.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the "DYNAMIC: DEVELOPMENT OF A BEHAVIORAL INTERVENTION FOR YOUNG ADULTS WITH ADVANCED CANCER" project at the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The project aims to develop and evaluate a behavioral intervention for young adult cancer patients, with a...
The National Cancer Institute (NCI) awarded a $657,121 Project Grant (CFDA 93.395 - Cancer Treatment Research) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant, awarded on December 12, 2024, will fund research to develop an effective dendritic cell therapy to treat leptomeningeal disease (LMD), which occurs in 5% of advanced stage breast cancer patients and has a very poor prognosis. The key products and services to be delivered include:...